The germline genetic component of drug sensitivity in cancer cell lines
Little is known about the contribution of germline genetic variants to cancer drug sensitivity. Here, the authors devise an approach for joint analysis of germline variants and somatic mutations, identifying substantial germline contributions to variation in drug sensitivity.
Guardado en:
Autores principales: | Michael P. Menden, Francesco Paolo Casale, Johannes Stephan, Graham R. Bignell, Francesco Iorio, Ultan McDermott, Mathew J. Garnett, Julio Saez-Rodriguez, Oliver Stegle |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5f22af9ae8a4bdfa6b0d4bf920d0315 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening
por: Gabriele Picco, et al.
Publicado: (2019) -
Sensitive periods during the development and expression of vertebrate sexual signals: A systematic review
por: Molly T. McDermott, et al.
Publicado: (2021) -
CoRe: a robustly benchmarked R package for identifying core-fitness genes in genome-wide pooled CRISPR-Cas9 screens
por: Alessandro Vinceti, et al.
Publicado: (2021) -
Single-cell states in the estrogen response of breast cancer cell lines.
por: Francesco Paolo Casale, et al.
Publicado: (2014) -
Development and Validation of an Advanced Actuator Line Model for Wind Turbines
por: Papi Francesco, et al.
Publicado: (2021)